Maze Therapeutics Inc
(MAZE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 12-2022 | |
| Sales | 165,000 | 0 | 0 | 0 |
| Gross Profit | 165,000 | N/A | N/A | N/A |
| Operating Expenses | 25,445 | 28,014 | 0 | 0 |
| Operating Income | 139,555 | -28,014 | N/A | N/A |
| Other Income | 1,227 | -4,480 | 0 | 0 |
| Pre-tax Income | 140,782 | -32,494 | 0 | 0 |
| Income Tax | 1,726 | N/A | N/A | N/A |
| Net Income Continuous | 139,056 | -32,494 | N/A | N/A |
| Net Income | $139,056 | $-32,494 | $N/A | $N/A |
| EPS Basic Total Ops | 5.92 | -13.91 | N/A | N/A |
| EPS Basic Continuous Ops | 58.21 | -13.90 | N/A | N/A |
| EPS Diluted Total Ops | 3.22 | -13.91 | N/A | N/A |
| EPS Diluted Continuous Ops | 32.23 | -13.90 | N/A | N/A |
| EBITDA(a) | $140,409 | $-27,064 | $N/A | $N/A |